OAM
IDXX icon

Oppenheimer Asset Management’s Idexx Laboratories IDXX Stock Holding History

Oppenheimer Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.1M Sell
28,648
-5,452
-16% -$3.5M 0.18% 130
2025
Q4 		$23.1M Buy
34,100
+3,930
+13% +$2.68M 0.28% 83
2025
Q3 		$19.3M Sell
30,170
-3,458
-10% -$2.1M 0.21% 117
2025
Q2 		$18M Buy
33,628
+22,150
+193% +$10.6M 0.21% 125
2025
Q1 		$4.82M Sell
11,478
-115
-1% -$49.9K 0.06% 323
2024
Q4 		$4.79M Sell
11,593
-288
-2% -$126K 0.06% 326
2024
Q3 		$6M Sell
11,881
-76
-0.6% -$36.9K 0.07% 288
2024
Q2 		$5.83M Buy
11,957
+1,453
+14% +$729K 0.07% 281
2024
Q1 		$5.67M Sell
10,504
-948
-8% -$518K 0.08% 265
2023
Q4 		$6.36M Sell
11,452
-351
-3% -$165K 0.09% 257
2023
Q3 		$5.16M Sell
11,803
-630
-5% -$314K 0.08% 273
2023
Q2 		$6.24M Sell
12,433
-326
-3% -$156K 0.09% 249
2023
Q1 		$6.38M Sell
12,759
-187
-1% -$89.5K 0.1% 231
2022
Q4 		$5.28M Sell
12,946
-293
-2% -$114K 0.09% 250
2022
Q3 		$4.31M Sell
13,239
-422
-3% -$155K 0.08% 279
2022
Q2 		$4.79M Sell
13,661
-423
-3% -$172K 0.08% 264
2022
Q1 		$7.71M Sell
14,084
-1,460
-9% -$768K 0.11% 222
2021
Q4 		$10.2M Sell
15,544
-561
-3% -$352K 0.14% 183
2021
Q3 		$10M Sell
16,105
-10,546
-40% -$7.09M 0.14% 172
2021
Q2 		$16.8M Sell
26,651
-204
-0.8% -$113K 0.24% 95
2021
Q1 		$13.1M Sell
26,855
-2,287
-8% -$1.15M 0.2% 122
2020
Q4 		$14.6M Sell
29,142
-903
-3% -$404K 0.24% 97
2020
Q3 		$11.8M Buy
30,045
+626
+2% +$231K 0.23% 110
2020
Q2 		$9.71M Buy
29,419
+9,509
+48% +$2.75M 0.2% 128
2020
Q1 		$4.82M Buy
19,910
+17,451
+710% +$4.55M 0.12% 200
2019
Q4 		$643K Sell
2,459
-159
-6% -$41.9K 0.01% 748
2019
Q3 		$712K Sell
2,618
-24
-0.9% -$6.68K 0.02% 712
2019
Q2 		$727K Sell
2,642
-87
-3% -$21.4K 0.02% 719
2019
Q1 		$610K Sell
2,729
-402
-13% -$83K 0.01% 746
2018
Q4 		$583K Buy
3,131
+56
+2% +$11.5K 0.01% 712
2018
Q3 		$767K Buy
3,075
+4
+0.1% +$971 0.02% 690
2018
Q2 		$669K Sell
3,071
-3,082
-50% -$635K 0.02% 711
2018
Q1 		$1.18M Sell
6,153
-579
-9% -$107K 0.03% 556
2017
Q4 		$1.05M Hold
6,732
– – 0.03% 584
2017
Q3 		$1.05M Sell
6,732
-1,151
-15% -$182K 0.03% 587
2017
Q2 		$1.27M Sell
7,883
-6,588
-46% -$1.07M 0.04% 509
2017
Q1 		$2.24M Buy
+14,471
New +$1.99M 0.06% 323

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oppenheimer Asset Management's IDXX Position: Q1 2026 in Review

Oppenheimer Asset Management reduced its Idexx Laboratories (IDXX) stake by 16% in Q1 2026, selling an estimated $3.5M and leaving 28,648 shares worth $16.1M. The position accounts for 0.18% of the portfolio, ranked #130.

Oppenheimer Asset Management first reported a position in IDXX in Q1 2017 and has held it in 37 quarters since. The position peaked at $23.1M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Oppenheimer Asset Management held 28,648 shares of Idexx Laboratories worth $16.1M as of Q1 2026.
  • Oppenheimer Asset Management sold 5,452 Idexx Laboratories shares in Q1 2026, an estimated $3.5M.
  • Idexx Laboratories made up 0.18% of Oppenheimer Asset Management's portfolio in Q1 2026, its #130 holding.
  • Oppenheimer Asset Management first reported a position in Idexx Laboratories in Q1 2017 and has held it in 37 quarters since.
  • Oppenheimer Asset Management's Idexx Laboratories position peaked at $23.1M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.